U.S. Health Secretary Halts Enforcement on Six Unapproved Peptides

U.S. Health Secretary Halts Enforcement on Six Unapproved Peptides

Health Politics
Sign in to pin this event

U. S. Health Secretary Robert F. Kennedy Jr. announced on October 28 in Washington, D.

C. , that the Department of Health and Human Services will cease enforcement against the sale of six compounded peptide drugs, despite FDA safety warnings. The announcement follows a temporary enforcement discretion the department granted earlier in the week, stating it would not pursue legal action against compounding pharmacies that produce the six peptides while a formal rule change is pending. Most FDA scientific staff had previously voiced opposition to the proposal, citing concerns about the compounds' safety.

Actors

U.S. Department of Health and Human Services Emily Hilliard Dr. Peter Lurie Shabbir Safdar Medivant Healthcare

Locations

Washington, D.C., United States

Articles

October 29, 2026
1 total
Health Secretary Kennedy expands access to unapproved peptide injections
Health Secretary Kennedy expands access to unapproved peptide injections

The Independent • 29 Oct 00:39

Robert F. Kennedy Jr. announced a policy that will stop enforcement against the sale of six compounded peptide compounds, despite FDA warnings about their safety.

Credibility 68% Manip. 12% Center
October 28, 2026
4 total
HHS permits small pharmacies to compound six non-FDA-approved peptides
HHS permits small pharmacies to compound six non-FDA-approved peptides

NPR • 28 Oct 22:26

The Department of Health and Human Services announced a policy allowing 503A compounding pharmacies to prepare six peptides that have not received FDA approval, sparking debate over safety and supply.

Credibility 73% Manip. 10% Center
Health Secretary Kennedy issues enforcement-discretion policy allowing compounding of six peptides
Health Secretary Kennedy issues enforcement-discretion policy allowing compounding of six peptides

Ars Technica • 28 Oct 22:17

Robert F. Kennedy, the U.S. Health Secretary, announced a policy that stops HHS from enforcing against compounding pharmacies that produce six specific peptide substances, despite FDA scientists’ safety concerns.

Credibility 55% Manip. 45% Left
FDA scientists resist HHS plan to relax enforcement on wellness peptides
FDA scientists resist HHS plan to relax enforcement on wellness peptides

The Guardian • 28 Oct 18:35

Most FDA scientific staff opposed a Health and Human Services proposal that would limit enforcement against specialty pharmacies selling unapproved peptide drugs, citing safety concerns.

Credibility 68% Manip. 25% Center
HHS grants temporary enforcement discretion for six unapproved peptides
HHS grants temporary enforcement discretion for six unapproved peptides

NBC News • 28 Oct 16:13

The Department of Health and Human Services will not pursue legal action against compounding pharmacies that produce six specific peptides while a formal rule change is pending.

Credibility 78% Manip. 30% Center

Related events